[Target molecules of anti-tumor drugs and cell checkpoints].
Sugimoto
K
K
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D002453:Cell Cycle / Q000187:drug effects*; D004249:DNA Damage / Q000187:drug effects; D004264:DNA Topoisomerases, Type I / Q000502:physiology*; D004317:Doxorubicin / Q000494:pharmacology*; D006801:Humans; D009336:Necrosis
D000970:Antineoplastic Agents; D004317:Doxorubicin; D004264:DNA Topoisomerases, Type I